Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1270 participants.

Also called NCT04097145

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,270 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04097145
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04097145. Randomized; no masking; primary purpose treatment. Start 2019-12-11 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Acronym
CLASP II TR
Condition
Tricuspid Regurgitation
Condition
Tricuspid Valve Insufficiency
Condition
Tricuspid Valve Disease
Intervention (Device)
Edwards PASCAL System
Intervention (Drug)
Optimal Medical Therapy
Intervention (Device)
Edwards PASCAL System
Intervention (Device)
Edwards PASCAL System
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct04097145
Content hash
c6f651d6391211980cfa229d1059316be5ab58b911cec16584e76d9aa4f29f03